Peter Sever

Author PubWeight™ 33.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med 2010 7.49
2 Systolic pressure is all that matters. Lancet 2008 3.42
3 Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet 2012 2.53
4 Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet 2010 2.24
5 Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. Am J Hum Genet 2010 2.15
6 Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. Am J Hum Genet 2009 2.04
7 Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet 2012 1.96
8 Blood pressure loci identified with a gene-centric array. Am J Hum Genet 2011 1.44
9 Urinary catecholamines and the relationship with blood pressure and pharmacological therapy. J Hypertens 2016 1.39
10 Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a). J Lipid Res 2012 1.17
11 Wave reflection predicts cardiovascular events in hypertensive individuals independent of blood pressure and other cardiovascular risk factors: an ASCOT (Anglo-Scandinavian Cardiac Outcome Trial) substudy. J Am Coll Cardiol 2010 1.13
12 Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study. Am J Hypertens 2004 0.96
13 Long-term antihypertensive treatment fails to improve E/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudy. Hypertension 2013 0.84
14 Differential effects of antihypertensive treatment on the retinal microcirculation: an anglo-scandinavian cardiac outcomes trial substudy. Hypertension 2009 0.83
15 Candesartan- and atenolol-based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertension. Stroke 2006 0.81
16 VALUE: analysis of results. Lancet 2004 0.80
17 Comparison of the effects of antihypertensive treatment with angiotensin II blockade and beta-blockade on carotid wall structure and haemodynamics: protocol and baseline demographics. J Renin Angiotensin Aldosterone Syst 2002 0.77
18 Effect of beta blockers (metoprolol or propranolol) on effect of simvastatin in lowering C-reactive protein in acute myocardial infarction. Am J Cardiol 2008 0.77
19 The VALUE trial: a commentary. J Renin Angiotensin Aldosterone Syst 2004 0.75
20 Expertise: no longer a sine qua non for guideline authors? J Hypertens 2017 0.75
21 Reply. J Hypertens 2017 0.75
22 Commentary. J Renin Angiotensin Aldosterone Syst 2015 0.75
23 Corrigendum: Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat Genet 2017 0.75
24 Resistant hypertension and renal denervation: who's kidding whom? J Renin Angiotensin Aldosterone Syst 2014 0.75